116 related articles for article (PubMed ID: 21473288)
1. iASPP is important for bladder cancer cell proliferation.
Liu T; Li L; Yang W; Jia H; Xu M; Bi J; Li Z; Liu X; Li Z; Jing H; Kong C
Oncol Res; 2011; 19(3-4):125-30. PubMed ID: 21473288
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral vector-mediated doxycycline-inducible iASPP gene targeted RNA interference in hepatocellular carcinoma.
Pang MS; Chen X; Lu B; Zhao J; Li BH; Wei YQ; Guo YJ
Chin J Cancer; 2010 Sep; 29(9):796-801. PubMed ID: 20800021
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of iASPP in human hepatocellular carcinoma cells inhibits cell proliferation and tumor growth.
Lin BL; Xie DY; Xie SB; Xie JQ; Zhang XH; Zhang YF; Gao ZL
Neoplasma; 2011; 58(3):205-10. PubMed ID: 21391736
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of inhibitor of apoptosis‑stimulating protein of p53 inhibits proliferation and promotes apoptosis of gastric cancer cells.
Wang LL; Xu Z; Peng Y; Li LC; Wu XL
Mol Med Rep; 2015 Aug; 12(2):1653-8. PubMed ID: 25846425
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
Yu J; Li L; Huang C
Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
[TBL] [Abstract][Full Text] [Related]
6. iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.
Chen J; Xie F; Zhang L; Jiang WG
BMC Cancer; 2010 Dec; 10():694. PubMed ID: 21192816
[TBL] [Abstract][Full Text] [Related]
7. ppGalNAc T1 as a potential novel marker for human bladder cancer.
Ding MX; Wang HF; Wang JS; Zhan H; Zuo YG; Yang DL; Liu JY; Wang W; Ke CX; Yan RP
Asian Pac J Cancer Prev; 2012; 13(11):5653-7. PubMed ID: 23317233
[TBL] [Abstract][Full Text] [Related]
8. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Bergamaschi D; Samuels Y; O'Neil NJ; Trigiante G; Crook T; Hsieh JK; O'Connor DJ; Zhong S; Campargue I; Tomlinson ML; Kuwabara PE; Lu X
Nat Genet; 2003 Feb; 33(2):162-7. PubMed ID: 12524540
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells.
Zhang B; Xiao HJ; Chen J; Tao X; Cai LH
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):219-24. PubMed ID: 21625267
[TBL] [Abstract][Full Text] [Related]
10. Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells.
Zhu HB; Yang K; Xie YQ; Lin YW; Mao QQ; Xie LP
World J Surg Oncol; 2013 Jan; 11():22. PubMed ID: 23356234
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA124 regulate cell growth of prostate cancer cells by targeting iASPP.
Chen J; Xiao H; Huang Z; Hu Z; Qi T; Zhang B; Tao X; Liu SH
Int J Clin Exp Pathol; 2014; 7(5):2283-90. PubMed ID: 24966937
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory member of the apoptosis-stimulating protein of p53 is overexpressed in bladder cancer and correlated to its progression.
Wu Z; Wang S; Xue P; Wang S; Wang G; Zhang W
Medicine (Baltimore); 2017 May; 96(19):e6640. PubMed ID: 28489738
[TBL] [Abstract][Full Text] [Related]
13. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
Zhang H; Jiang H; Wang W; Gong J; Zhang L; Chen Z; Ding Q
Urol Oncol; 2012; 30(6):920-7. PubMed ID: 21478038
[TBL] [Abstract][Full Text] [Related]
14. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
[TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells.
Li G; Wang R; Gao J; Deng K; Wei J; Wei Y
Mol Cell Biochem; 2011 Apr; 350(1-2):193-200. PubMed ID: 21184255
[TBL] [Abstract][Full Text] [Related]
16. siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
Liu H; Wang M; Diao S; Rao Q; Zhang X; Xing H; Wang J
Leuk Res; 2009 Sep; 33(9):1243-8. PubMed ID: 19299014
[TBL] [Abstract][Full Text] [Related]
17. CDC20, a potential cancer therapeutic target, is negatively regulated by p53.
Kidokoro T; Tanikawa C; Furukawa Y; Katagiri T; Nakamura Y; Matsuda K
Oncogene; 2008 Mar; 27(11):1562-71. PubMed ID: 17873905
[TBL] [Abstract][Full Text] [Related]
18. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel piRNAs in bladder cancer.
Chu H; Hui G; Yuan L; Shi D; Wang Y; Du M; Zhong D; Ma L; Tong N; Qin C; Yin C; Zhang Z; Wang M
Cancer Lett; 2015 Jan; 356(2 Pt B):561-7. PubMed ID: 25305452
[TBL] [Abstract][Full Text] [Related]
20. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
